https://en.sputniknews.africa/20230720/russia-ready-to-supply-drugs-for-nuclear-treatment-of-cancer-to-brics-countries-1060654809.html
Russia Ready to Supply Drugs for Nuclear Treatment of Cancer to BRICS Countries
Russia Ready to Supply Drugs for Nuclear Treatment of Cancer to BRICS Countries
Sputnik Africa
Thursday sees the International Expert Forum on Nuclear Medicine of BRICS countries, gathering ambassadors of the states, health authorities, scientists... 20.07.2023, Sputnik Africa
2023-07-20T12:52+0200
2023-07-20T12:52+0200
2023-08-03T10:50+0200
russia
health
healthcare
brics
drugs
rosatom
international
https://cdn1.img.sputniknews.africa/img/103657/09/1036570984_0:161:3071:1888_1920x0_80_0_0_123191c0e12641ef70787472fa632380.jpg
Russian state nuclear corporation Rosatom is ready to provide BRICS countries with new high-tech radiopharmaceuticals for cancer treatment, the company's senior executive Kirill Komarov said.The official noted that through the range of isotopes supplied and through the development of radiopharmaceuticals based on them, Rosatom has "good opportunities to expand its long-standing cooperation" with the BRICS countries.As Komarov recalled, this January, Rosatom started building the largest European plant for the production of world-class radiopharmaceuticals in Russia's Obninsk. The facility is expected to ensure Russia's technological sovereignty in this high-tech field.After the launch of the plant, Rosatom intends to extend the range of radiopharmaceuticals produced in Russia to 25 or more items from the current 11, Komarov added.Earlier, Rosatom told Sputnik that it plans to start mining uranium in Namibia in 2029 with an estimated investment of 500 million USD.The project would increase Namibia's GDP by 1-2% in annual terms, Rosatom stressed.
https://en.sputniknews.africa/20230719/1060623424.html
russia
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
2023
Maxim Grishenkin
https://cdn1.img.sputniknews.africa/img/07e7/0a/17/1063018107_0:0:1104:1103_100x100_80_0_0_03090c85a11f5d2e8a19cf1d989443c9.jpg
Maxim Grishenkin
https://cdn1.img.sputniknews.africa/img/07e7/0a/17/1063018107_0:0:1104:1103_100x100_80_0_0_03090c85a11f5d2e8a19cf1d989443c9.jpg
News
en_EN
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rosiya Segodnya“
Maxim Grishenkin
https://cdn1.img.sputniknews.africa/img/07e7/0a/17/1063018107_0:0:1104:1103_100x100_80_0_0_03090c85a11f5d2e8a19cf1d989443c9.jpg
russia, health, healthcare, brics, drugs, rosatom, international
russia, health, healthcare, brics, drugs, rosatom, international
Russia Ready to Supply Drugs for Nuclear Treatment of Cancer to BRICS Countries
12:52 20.07.2023 (Updated: 10:50 03.08.2023) Thursday sees the International Expert Forum on Nuclear Medicine of BRICS countries, gathering ambassadors of the states, health authorities, scientists, representatives of pharmaceutical companies, and research and high-tech centers from Russia, Brazil, India, China, South Africa.
Russian state nuclear corporation Rosatom is ready to provide BRICS countries with new high-tech radiopharmaceuticals for cancer treatment, the company's senior executive Kirill Komarov said.
"Rosatom is working on the whole line of nuclear medicine - from the production of radioactive isotopes to the construction of centers providing high-tech care to the population," Komarov said.
The official noted that through the range of isotopes supplied and through the development of radiopharmaceuticals based on them, Rosatom has "good opportunities
to expand its long-standing cooperation" with the BRICS countries.
As Komarov recalled, this January, Rosatom started building the largest European plant for the production of world-class radiopharmaceuticals in Russia's Obninsk. The facility is expected to ensure Russia's technological sovereignty in this high-tech field.
In 2025, the new plant's 21 technological lines are expected to produce radiopharmaceutical products based on lutetium-177, actinium-225, radium-223 and other isotopes for the treatment of inoperable metastatic forms of cancer.
After the launch of the plant,
Rosatom intends to extend the range of radiopharmaceuticals produced in Russia to 25 or more items from the current 11, Komarov added.
"I am confident that these radiopharmaceuticals will be in demand not only in our country, but also by all our BRICS partners," he emphasized.
Earlier, Rosatom told Sputnik that it plans to start mining uranium in Namibia in 2029 with an estimated investment of 500 million USD.
The project would increase Namibia's GDP by 1-2% in annual terms, Rosatom stressed.
